Show source-provided references
1. Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation
2. A novel resorbable embolization microsphere for transient uterine artery occlusion: A comparative study with trisacryl-gelatin microspheres in the Sheep Model
10.1016/j.jvir.2014.06.025 ↗3. Kessel, D., and Ray, C. (2010). Transcatheter embolization and therapy. Techniques in Interventional Radiology, Springer. [1st ed.].
10.1007/978-1-84800-897-7 ↗4. Food and Drug Administration Center for Devices and Radiological Health (2004). Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.
5. Kehoe, S., Amensag, S., Looney, M., Abraham, R.J., and Boyd, D. (2015). “Imageable” zinc-silicate glass microspheres for transarterial embolization: A renal artery embolization study. Biomed. Glasses, 1.
10.1515/bglass-2015-0007 ↗9. An overview of Poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering
10.3390/ijms15033640 ↗10. Poly Lactic-co-Glycolic ACID (PLGA) as biodegradable controlled drug delivery carrier
10.3390/polym3031377 ↗12. Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms
10.1002/jps.21176 ↗13. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip
10.1163/1568562041959991 ↗14. Polymer degradation and drug delivery in PLGA-based drug–polymer applications: A review of experiments and theories
10.1002/jbm.b.33648 ↗17. Bio-absorbable polymers in implantation—An overview
18. A preclinical study of the safety and efficacy of OcclusinTM 500 artificial embolization device in Sheep
10.1007/s00270-011-0218-7 ↗19. Revised 501(k) Summary for IMBiotechnologies Ltd. (2017, June 20). Occlusin 500 Artificial Embolization Device (Per 21CFR 807.92), Available online: https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093813.pdf.
20. Retrospective study of the impact of fellowship training on two quality and safety measures in uterine artery embolization
10.1016/j.jacr.2013.09.020 ↗22. Temporary uterine artery occlusion for treatment of menorrhagia and uterine fibroids using an incisionless Doppler-guided transvaginal clamp: Case report
10.1093/humrep/dei299 ↗23. (2017, July 11). “Use of International Standard ISO-10993, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing” PDF, Available online: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm348890.pdf.
24. Merit Medical Systems, Inc. (2017, July 11). Embosphere Microspheres Brochure. Available online: https://www.merit.com/interventional-oncology-spine/embolotherapy/microspheres/embosphere-microspheres/#tab-id-2.
25. Swielim, G.E.A. (2006). ATLAS—Anatomy of Sheep, Ktab INC.
26. Veronese, F.M. (2009). PEG and PEG conjugates toxicity: Towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals. PEGylates Protein Drugs: Basic Science and Clinical Applications, Birkhauser Verlag.
27. Magnon, L., Laurent, A., Wassef, M., Bedouet, L., Louguet, S., Verret, V., and Servais, E. (2012). Implantable Swellable Bio-Resorbable Polymer. (Patent 2012/120138).
28. Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model
10.1016/j.jvir.2013.05.058 ↗29. ASTM E11-17 (2017). Standard Specification for Woven Wire Test Sieve Cloth and Test Sieves, ASTM International. Available online: https://www.astm.org/Standards/E11.htm.
30. Ong, J.L., Appleford, M.R., and Mani, G. (2013). Introduction to Biomaterials: Basic Theory with Engineering Applications, Cambridge University Press.
32. Nanosoft Polymers (2017, June 20). PLGA-PEG-PLGA. Available online: https://www.nanosoftpolymers.com/product/plga-peg-plga/.
33. Interaction of chitosan with natural or synthetic anionic polyelectrolytes. 1. The chitosan–carboxymethylcellulose complex
10.1016/j.carbpol.2005.07.004 ↗35. In vitro enzymatic degradation kinetics of polymeric blends of crosslinked starch and carboxymethyl cellulose
10.1002/pi.1878 ↗36. Synthesis and characterization of carboxymethylcellulose-methacrylate hydrogel cell scaffolds
10.3390/polym2030252 ↗37. Synthesis and in vitro characterizations of porous carboxymethyl cellulose-poly(ethylene oxide) hydrogel film
10.1186/s40824-015-0033-3 ↗41. The controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivo
42. Calibrated bioresorbable microspheres: A preliminary study on the level of occlusion and arterial distribution in a rabbit kidney model
10.1016/j.jvir.2013.06.009 ↗47. Chitin-based embolic materials in the renal artery of rabbits: Pathologic evaluation of an absorbable particulate agent
10.1148/radiol.2361040669 ↗52. Requirements and selection of an animal model
53. Standring, S. (2016). Gray’s Anatomy: The Anatomical Basis of Clinical Practice, Elsevier Limited. [41st ed.].
56. Polyvinyl Alcohol Particle Size for Uterine Artery Embolization: A Prospective Randomized Study of Initial Use of 350–500μm Particles versus Initial Use of 500–700 μm Particles
10.1016/j.jvir.2010.09.018 ↗57. The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres
10.1258/002367799780578372 ↗